Navigation Links
YM BioSciences announces presentations on global nimotuzumab trials at ASCO annual meeting
Date:5/21/2010

mab) in patients with advanced (stage III or IVa) squamous cell carcinoma of head and neck (SCCHN): Four-year survival results from a phase IIb study (abstract # 5530)" will be presented in the Head and Neck Cancer general poster session on Friday June 4th from 2:00PM until 6:00PM in S403, with discussion from 5:00PM until 6:00PM in S406, the Vista Room. This randomized trial demonstrates that the benefit of adding nimotuzumab to radiation and chemoradiation is durable and persists for several years.

The poster entitled "Results from a pilot study of nimotuzumab with concurrent chemoradiation in patients with locally advanced squamous cell carcinoma of head and neck (abstract # 5565)" will be presented in the Head and Neck Cancer general poster session on Sunday June 6th from 8:00AM until 12:00PM in S Hall A2. This study indicates improved outcomes in terms of locoregional response with the addition of nimotuzumab and is consistent with randomized clinical data in this indication being presented at the same setting.

About YM BioSciences

YM BioSciences Inc. is a life sciences product development company. Together with the products from YM BioSciences Australia, the Company is currently developing four late-stage products: nimotuzumab, an EGFR-targeting Affinity-Optimized Antibody(TM); CYT387, a JAK 1/2 small molecule inhibitor; CYT997, a potent, vascular disrupting agent (VDA); and AeroLEF(R), a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl. YM has proven regulatory and clinical trial expertise and a diversified business model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization.

Nimotuz
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
6. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
11. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... KENNESAW, Ga. , May 20, 2013  MiMedx ... developer, manufacturer and marketer of patent protected regenerative biomaterials ... that it has secured a revolving line of credit ... facility, which is secured by the Company,s accounts receivable ... million through May 1, 2014.  The facility will be ...
(Date:5/20/2013)... New York, NY (PRWEB) May 20, 2013 ... My Cleaning Products said that although bed bugs need to ... elimination process will not compromise a person's health. And so ... a guide how to get rid of bed bugs ... recommended its non-pesticide bed bug spray it called Bed Bug ...
(Date:5/20/2013)... PA (PRWEB) May 20, 2013 Interventional ... Allegheny General Hospital (AGH) Cardiovascular Institute have ... coronary artery disease (CAD) over the past ... such as balloon angioplasty and coronary artery stent implantation. ... once again play a prominent role in the study ...
(Date:5/20/2013)... May 20, 2013 In Early 2013, ... field of biotoxin related illnesses , announced his vision ... able to advance his protocol for treating Chronic Inflammatory ... the third physician to achieve certification in the Shoemaker ... able to practice the Shoemaker Protocol in other parts ...
Breaking Biology Technology:New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2
... Mental Health Programs Supported by a Grant from Otsuka ... America Pharmaceutical, Inc., ... named three nonprofit organizations and one individual,as the recipients of the ... presented at the 2008 APF Annual Benefit in,Washington, D.C. Each organization ...
... the patient,s own whole blood, SOMERS, Conn., May ... the health professionals who manage patients on heart and,lung ... Blood,Resources, online waste calculator can be used to estimate ... machines most commonly used,during heart surgery to salvage the ...
... and some clever chemistry, University of California, Berkeley, researchers ... the sugar coating on their cells. , This novel ... that coat cells is a new tool for those ... because its transparent embryos allow easy observation of living ...
Cached Biology Technology:American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5Global Blood Resources' On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions 2Global Blood Resources' On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions 3Glowing zebrafish help researchers track role of sugars in the cell 2Glowing zebrafish help researchers track role of sugars in the cell 3
(Date:5/17/2013)... new Dartmouth College study finds human-caused climate change ... tropical lizards, contradicting a host of recent studies ... warming planet. , The findings, which appear in ... new hope for survival of a creature thought ... predictions that tropical cold-blooded animals, especially forest lizards, ...
(Date:5/17/2013)... team of scientists using a new X-ray method recorded ... frog embryo in greater detail than ever before., This ... and the search for new treatments for genetic diseases., ... Technologie in Germany, in collaboration with the Advanced Photon ... Laboratory, released the most precise depiction ever of the ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) ... The Endocrine Society (ENDO) 95th Annual Meeting in ... awards are meant to promote the entry of ... the mainstream of the basic science community and ... the ENDO 2013 Annual Meeting. , Awards are ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2New X-ray method shows how frog embryos could help thwart disease 2
... More than 300 geoscientists will gather 12-13 March for ... the Geological Society of America. The meeting takes place ... Petersburg, Florida. , Geoscientists from the University of South ... along with the USF Geology Alumni Society. Journalists ...
... Polymorphisms are variations in genes which can result in ... thus may be associated with susceptibility to common diseases. ... a journal of the Association for Psychological Science, psychologist ... Institutet in Sweden and the University of Greifswald in ...
... Finding molecules that block the activity of the oncogene ... literally millions of compounds, using computers that compared the structure ... said a Baylor College of Medicine researcher in a report ... PLoS One (Public Library of Science ONE). ...
Cached Biology News:The genetics of fear: Study suggests specific genetic variations contribute to anxiety disorders 2Small molecules block cancer gene 2